{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:11:22Z","timestamp":1787242282150,"version":"build-2736575974"},"reference-count":34,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Over the past decades, interest in second breast-conserving therapy (BCT) has increased due to, among others, advances in radiotherapy techniques. Preoperative partial breast irradiation (PBI) is an experimental treatment for patients with low-risk primary breast cancer. This approach can downstage the tumour and may possibly reduce toxicity and improve cosmetic outcomes compared with postoperative radiotherapy. This study aims to evaluate the feasibility of single-dose preoperative PBI and second breast-conserving surgery (BCS) for patients with an ipsilateral recurrent breast event (IRBE) after previous BCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The REPEAT trial is a multicentre, prospective, single-arm trial investigating ablative single-dose preoperative PBI in patients with an IRBE. Eligible patients are \u226550 years, have a unifocal non-lobular invasive breast cancer \u22642\u2009cm, Bloom-Richardson grade 1 or 2, oestrogen receptor-positive, human epidermal growth factor receptor 2-negative and clinically negative axillary lymph nodes. The study plans to enrol 25 patients. Radiotherapy planning will involve the use of CT and MRI in the treatment position. Single-dose PBI of 20\u2009Gy to the tumour and 15\u2009Gy to the surrounding 2\u2009cm of breast tissue will be delivered using a conventional or MR-guided linear accelerator. Tumour response will be monitored preoperatively using MRI and liquid biopsies to identify biomarkers for evaluating radiosensitivity. BCS will be performed 3 (\u00b1one) weeks post PBI. The primary endpoint is the incidence of grade 2 or higher treatment-associated acute toxicity within 90 days. Secondary endpoints include the evaluation of acute (grade 1) and late toxicity, radiologic and pathologic response, mastectomy rate, patient-reported outcomes, cosmetic outcome, local, regional and distant recurrence rates, survival outcome and biomarkers in liquid biopsies and tumour tissue. Patients will be followed up to 5 years after PBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval from the Medical Research Ethics Committee of the Amsterdam UMC has been obtained (NL85983.018.24). The results will be disseminated via peer-reviewed academic journal and presentation at conferences. In addition, summaries will be shared with the participating patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      The trial was registered prospectively on October 11\n                      <jats:sup>th<\/jats:sup>\n                      2024 at clinicaltrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clinical-trials-gov\" xlink:href=\"NCT06640881\">NCT06640881<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-096510","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:59:36Z","timestamp":1753088376000},"page":"e096510","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative partial breast reirradiation and repeat breast-conserving surgery in patients with recurrent breast cancer: the prospective single-arm REPEAT trial \u2013 a study protocol"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06640881","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05350722","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06640881","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-2451","authenticated-orcid":false,"given":"Yasmin","family":"Civil","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisca","family":"Wurfbain","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne","family":"Jonker","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"van der Sangen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Catharina Hospital, Eindhoven, Noord-Brabant, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Oei","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Duvivier","sequence":"additional","affiliation":[{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Radiology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bijker","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meijnen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"van Kesteren","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Palacios","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Barb\u00e9","sequence":"additional","affiliation":[{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Pathology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien","family":"Menke-van der Houven van Oordt","sequence":"additional","affiliation":[{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Medical Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Diepenhorst","sequence":"additional","affiliation":[{"name":"Department of Surgery, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Department of Surgery, Flevo Hospital, Almere, Flevoland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Thijssen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Slotman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Verhoeff","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"Schipper","sequence":"additional","affiliation":[{"name":"Department of Surgery, Catharina Hospital, Eindhoven, Noord-Brabant, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"van den Bongard","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amsterdam UMC Location VUmc, Amsterdam, Noord-Holland, The Netherlands"},{"name":"Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands"},{"name":"Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2025071803052239000_15.7.e096510.1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"2025071803052239000_15.7.e096510.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"2025071803052239000_15.7.e096510.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31145-5"},{"key":"2025071803052239000_15.7.e096510.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.01.014"},{"key":"2025071803052239000_15.7.e096510.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00650"},{"key":"2025071803052239000_15.7.e096510.6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","article-title":"Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis","volume":"117","author":"Hannoun-Levi","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025071803052239000_15.7.e096510.7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025071803052239000_15.7.e096510.8","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1200\/JCO.19.02806","article-title":"Multidisciplinary Management of Locoregional Recurrent Breast Cancer","volume":"38","author":"Buchholz","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025071803052239000_15.7.e096510.9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ejso.2019.02.008","article-title":"Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review","volume":"45","author":"Walstra","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"2025071803052239000_15.7.e096510.10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clon.2017.11.004","article-title":"Re-irradiation and Hyperthermia in Breast Cancer","volume":"30","author":"Kaidar-Person","year":"2018","journal-title":"Clin Oncol"},{"key":"2025071803052239000_15.7.e096510.11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology\/RTOG 1014 Phase 2 Clinical Trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025071803052239000_15.7.e096510.12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13233-9"},{"key":"2025071803052239000_15.7.e096510.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.04.063"},{"key":"2025071803052239000_15.7.e096510.14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","article-title":"Tumor Response After Neoadjuvant Magnetic Resonance Guided Single Ablative Dose Partial Breast Irradiation","volume":"106","author":"Vasmel","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025071803052239000_15.7.e096510.15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10910-6"},{"key":"2025071803052239000_15.7.e096510.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00589-1"},{"key":"2025071803052239000_15.7.e096510.17","unstructured":"Federatie Medisch Specialisten . Treatment of breast cancer. Richtlijn \u2019behandeling van het mammacarcinoom'. 2017. Available: https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/behandeling_invasief_carcinoom.html [Accessed 5 Sep 2024]."},{"key":"2025071803052239000_15.7.e096510.18","unstructured":"Kwaliteitsborging mensgebonden onderzoek: nederlandse federatie van universitair medische centra. 2020. Available: https:\/\/www.nfu.nl\/sites\/default\/files\/2021-01\/21.00023_Richtlijn_Kwaliteitsborging_Mensgebonden_Onderzoek_2020.pdf [Accessed 5 Sep 2024]."},{"key":"2025071803052239000_15.7.e096510.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020989"},{"key":"2025071803052239000_15.7.e096510.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0418-y"},{"key":"2025071803052239000_15.7.e096510.21","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16244970","article-title":"Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis","volume":"16","author":"Ng","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025071803052239000_15.7.e096510.22","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2022.0631","article-title":"Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction","volume":"157","author":"Hanson","year":"2022","journal-title":"JAMA Surg"},{"key":"2025071803052239000_15.7.e096510.23","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06154-2"},{"key":"2025071803052239000_15.7.e096510.24","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.22.01485","article-title":"Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial","volume":"41","author":"Meduri","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025071803052239000_15.7.e096510.25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl424"},{"key":"2025071803052239000_15.7.e096510.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.007"},{"key":"2025071803052239000_15.7.e096510.27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.26921","article-title":"Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis","volume":"3","author":"Cullinane","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025071803052239000_15.7.e096510.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.11.398"},{"key":"2025071803052239000_15.7.e096510.29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2013.10.033","article-title":"Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation","volume":"110","author":"van der Leij","year":"2014","journal-title":"Radiother Oncol"},{"key":"2025071803052239000_15.7.e096510.30","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.4479"},{"key":"2025071803052239000_15.7.e096510.31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ejso.2010.05.009","article-title":"Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure","volume":"36","author":"Derkx","year":"2010","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"2025071803052239000_15.7.e096510.32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1245\/s10434-018-6358-0","article-title":"Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Systematic Review of the Results and Impact on Prognosis","volume":"25","author":"Poodt","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2025071803052239000_15.7.e096510.33","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11097"},{"key":"2025071803052239000_15.7.e096510.34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-022-06654-9","article-title":"Added value of repeat sentinel lymph node biopsy in FDG-PET\/CT node-negative patients with ipsilateral breast cancer recurrence","volume":"194","author":"Haarsma","year":"2022","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-096510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:59:40Z","timestamp":1753088380000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-096510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2024-096510"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-096510","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}